IL106592A - Peptides and analogues and their mixtures for the detection and isolation of antibodies to the E1 and E2 protein of the rubella virus - Google Patents

Peptides and analogues and their mixtures for the detection and isolation of antibodies to the E1 and E2 protein of the rubella virus

Info

Publication number
IL106592A
IL106592A IL10659293A IL10659293A IL106592A IL 106592 A IL106592 A IL 106592A IL 10659293 A IL10659293 A IL 10659293A IL 10659293 A IL10659293 A IL 10659293A IL 106592 A IL106592 A IL 106592A
Authority
IL
Israel
Prior art keywords
peptide
bch
peptides
rubella
mixture
Prior art date
Application number
IL10659293A
Other languages
English (en)
Hebrew (he)
Other versions
IL106592A0 (en
Original Assignee
Biochem Immunosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochem Immunosystems Inc filed Critical Biochem Immunosystems Inc
Publication of IL106592A0 publication Critical patent/IL106592A0/xx
Publication of IL106592A publication Critical patent/IL106592A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL10659293A 1992-08-07 1993-08-04 Peptides and analogues and their mixtures for the detection and isolation of antibodies to the E1 and E2 protein of the rubella virus IL106592A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/927,071 US5427792A (en) 1989-08-23 1992-08-07 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus

Publications (2)

Publication Number Publication Date
IL106592A0 IL106592A0 (en) 1993-12-08
IL106592A true IL106592A (en) 2001-01-11

Family

ID=25454125

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10659293A IL106592A (en) 1992-08-07 1993-08-04 Peptides and analogues and their mixtures for the detection and isolation of antibodies to the E1 and E2 protein of the rubella virus

Country Status (13)

Country Link
US (1) US5427792A (de)
EP (1) EP0656013B1 (de)
JP (1) JP3492686B2 (de)
AP (1) AP453A (de)
AT (1) ATE192163T1 (de)
AU (1) AU690070B2 (de)
CA (1) CA2141670C (de)
DE (1) DE69328488T2 (de)
ES (1) ES2145055T3 (de)
IL (1) IL106592A (de)
PT (1) PT656013E (de)
WO (1) WO1994003490A1 (de)
ZA (1) ZA935642B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238660A1 (en) * 1998-05-22 1999-11-22 Janet Chantler Gene sequences of rubella virus associated with attenuation
WO2000033081A1 (en) * 1998-12-01 2000-06-08 Viral Antigens, Inc. IMPROVED SPECIFICITY IN THE DETECTION OF ANTI-RUBELLA IgM ANTIBODIES
BR102018075339A2 (pt) * 2018-12-06 2021-11-16 Fundação Oswaldo Cruz Proteína recombinante, sequência de dna sintético, vetor de expressão, célula hospedeira, composição, kit para diagnóstico de rubéola, uso de pelo menos uma proteína recombinante, e, métodos para produzir uma proteína recombinante e para diagnóstico de rubéola
CN110423272A (zh) * 2019-08-15 2019-11-08 捷敏(天津)生物技术有限公司 一种新的抗风疹病毒膜蛋白e1的抗体及其应用技术领域

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003206A1 (en) * 1985-11-25 1987-06-04 Quash Gerard A Modified viral glycoproteins, diagnostic and therapeutic uses therefore
GB2206587A (en) * 1987-07-08 1989-01-11 London Biotechnology Ltd Rubella e1 glycoprotein antigens
US5164481A (en) * 1989-08-23 1992-11-17 Iaf Biochem International Inc. Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine

Also Published As

Publication number Publication date
ATE192163T1 (de) 2000-05-15
PT656013E (pt) 2000-10-31
AU4693493A (en) 1994-03-03
WO1994003490A1 (en) 1994-02-17
ZA935642B (en) 1995-02-06
AU690070B2 (en) 1998-04-23
CA2141670C (en) 2007-03-06
CA2141670A1 (en) 1994-02-17
DE69328488T2 (de) 2000-11-30
ES2145055T3 (es) 2000-07-01
EP0656013B1 (de) 2000-04-26
JPH08502724A (ja) 1996-03-26
AP9300556A0 (en) 1993-10-31
US5427792A (en) 1995-06-27
EP0656013A1 (de) 1995-06-07
JP3492686B2 (ja) 2004-02-03
IL106592A0 (en) 1993-12-08
AP453A (en) 1996-01-20
DE69328488D1 (de) 2000-05-31

Similar Documents

Publication Publication Date Title
KR100602553B1 (ko) 구제역에 대한 합성 펩티드 백신
JP3477198B2 (ja) Ｃ型肝炎ウィルス（ｈｃｖ）に対する抗体の検出のためのペプチド及びその混合物
CA1336473C (en) Synthetic peptide antigens for the detection of hiv-1 infection
CA2441677A1 (en) Peptides and mixtures thereof for detecting antibodies to severe acute respiratory syndrome-associated coronavirus
AU646641B2 (en) Rubella peptides
CA2086922C (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
IE871289L (en) Peptides, antibodies, vaccines and assay methods.
JP3390002B2 (ja) Ｈｔｌｖ―ｉおよびｈｔｌｖ―ｉｉウイルスに対する抗体を検出するためのペプチドおよびアナログおよびその混合物
JPH01224397A (ja) Ｈｉｖ抗体を検出するための合成ペプチド及びその混合物
EP0477301A1 (de) Peptide oder davon abgeleitete antikörper zur diagnose von, zur therapie, und zur einimpfung gegen htlv-1-infektion
US5427792A (en) Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
GB2173504A (en) Peptides useful in vaccination against enteroviruses
US5359029A (en) Peptides and analogues and mixtures thereof for detecting antibodies to HTLV-I and HTLV-II viruses
NZ235538A (en) Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
CA1338028C (en) Synthetic peptide antigens for the detection of hiv-1 infection
CA2428443A1 (en) Peptides and mixtures thereof for detecting antibodies to severe acute respiratory syndrome-associated coronavirus

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees